Forget the drug discovery hype. Here’s how the world’s largest pharma company is seeing a payoff from AI right now. There’s been huge hype around AI’s potential for drug discovery. But at Eli Lilly, ...
Eli Lilly is a market darling at the moment because of its industry-leading GLP-1 drugs. The stock looks priced for perfection despite a well-known drug cycle. That's good news, but investors are well ...
Eli Lilly & Co will invest $3 billion in China over the next decade to expand local production, with a focus on weight loss as the US drugmaker looks to cement its dominance in the booming obesity ...
Eli Lilly stock is down 13% from its 52-week high. Analysts still see some decent upside for the stock, with its average price target being north of $1,200. The company experienced tremendous growth ...
SHANGHAI, March 11 (Reuters) - Eli Lilly (LLY.N), opens new tab plans to invest $3 billion in China over the next decade, which will help build production capacity for its experimental type-2 ...
A fan’s request put royal protocol to the test during the Prince and Princess of Wales’ visit to Powys Max Mumby/Indigo/Getty Kate Middleton declined signing an autograph for a fan during an outing in ...
CHONGQING, CHINA - JANUARY 29: In this photo illustration, a smartphone displays the logo of Eli Lilly and Company (NYSE: LLY), a U.S.-based pharmaceutical company specializing in prescription ...
Announcing the submission of a marketing application for its experimental weight loss drug, orforglipron, in China, Eli Lilly (LLY) said on Wednesday that it plans to invest $3B in the country over ...
Believe it or not, Luke Combs has a low-key side hustle — buying, selling and trading sports cards. Combs even started a side Instagram account that’s followed by some country music heavyweights, and ...
BUFFALO, N.Y. (WIVB) — Following one of the most memorable Buffalo Sabres games in years, two members of the team — Jack Quinn and Zach Benson — signed autographs for fans at Dave and Adam’s Card ...
Eli Lilly stock is down 13% from its 52-week high. Analysts still see some decent upside for the stock, with its average price target being north of $1,200. The company experienced tremendous growth ...
Hollywood’s biggest names gathered for more than just awards season celebrations as the Elton John AIDS Foundation hosted its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results